Spatially mapping the immune landscape of melanoma using imaging mass cytometryDan Moldoveanu, Ian R. Watson, Nicholas Bertos et al.|Science Immunology|2022Cited by 131
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant MelanomasMatthew Dankner, April A. N. Rose, Mathieu Lajoie et al.|Clinical Cancer Research|2018Cited by 76
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Ian R. Watson, Dan Moldoveanu et al.|Cell Reports|2025Cited by 7
Raw CyTOF images associated with Moldoveanu et al. 2022, Science ImmunologyDan Moldoveanu, Ian R. Watson, LeeAnn Ramsay et al.|Zenodo (CERN European Organization for Nuclear Research)|2022Cited by 1
Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.Dan Moldoveanu, Ian R. Watson, Mathieu Lajoie et al.|Journal of Clinical Oncology|2018Cited by 0